White Paper
Study Start-Up Challenges: Hard Realities, Effective Strategies
Learn ways to speed up site activation and provide a consistent site experience
May 14, 2024
  • Library
  • Study Start-Up Challenges: Hard Realities, Effective Strategies

Get instant access

Download

Study start-up timelines are slowing down, causing delays in product launches and ROI.

This white paper summarizes a discussion with Kerry Randall, Vice President and Global Head of Site Activation for IQVIA R&D Solutions, Raphaëlle Gilg, Strategy and Operations Manager for Novartis Pharmaceuticals, Rodrigo Guimarães, Vice President of Global Site Activation for IQVIA R&D Solutions, and Rosemary Shirey, Associate Director of Client Services for IQVIA Technologies.

You may also be interested in

Webinar
Practical Approaches to Faster Study Start-Ups: Making Progress in the Face of Industry Headwinds
Blog
Practical Approaches To Faster Study Start-Ups: Q&A With Industry Leaders
By: Raphaëlle Gilg, Kerry Randall, Rodrigo Guimarães, Rosemary Shirey
Blog
How Technology Is Accelerating Site Activation: Examples From Novartis And IQVIA
By: Rosemary Shirey
Fact Sheet
Orchestrated Study Start-Up with the IQVIA Investigator Site Portal
Prev
Next

Related solutions

Site Suite

Increase transparency, improve communications and reduce administrative burden for all clinical trial stakeholders.

Investigator Site Portal

Communication, collaboration and transparency between sites and sponsors mean trials start up and close out faster.

Contact Us